THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $912,000 | -32.3% | 2,320,126 | -1.9% | 0.00% | – |
| Q1 2017 | $1,348,000 | +49.0% | 2,366,223 | +15.3% | 0.00% | – |
| Q4 2016 | $905,000 | -21.9% | 2,052,520 | +20.1% | 0.00% | – |
| Q3 2016 | $1,159,000 | -32.4% | 1,709,592 | -36.6% | 0.00% | – |
| Q2 2016 | $1,714,000 | +29.8% | 2,697,460 | -6.1% | 0.00% | – |
| Q1 2016 | $1,321,000 | +15.0% | 2,871,366 | +19.9% | 0.00% | – |
| Q4 2015 | $1,149,000 | -86.5% | 2,394,462 | +14.8% | 0.00% | – |
| Q3 2015 | $8,487,000 | +10.2% | 2,085,272 | +9.3% | 0.00% | -100.0% |
| Q2 2015 | $7,704,000 | +6.8% | 1,906,989 | +7.3% | 0.00% | – |
| Q1 2015 | $7,216,000 | +48.2% | 1,777,521 | +16.1% | 0.00% | – |
| Q4 2014 | $4,870,000 | -9.4% | 1,531,443 | +2.9% | 0.00% | – |
| Q3 2014 | $5,373,000 | -3.4% | 1,488,247 | +5.9% | 0.00% | – |
| Q2 2014 | $5,563,000 | -19.8% | 1,404,880 | -3.6% | 0.00% | -100.0% |
| Q1 2014 | $6,938,000 | +13.4% | 1,457,490 | +11.2% | 0.00% | 0.0% |
| Q4 2013 | $6,119,000 | +1.7% | 1,310,212 | +1.3% | 0.00% | 0.0% |
| Q3 2013 | $6,015,000 | -4.0% | 1,293,573 | +8.5% | 0.00% | 0.0% |
| Q2 2013 | $6,268,000 | – | 1,191,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 4,003,992 | $1,922,000 | 0.85% |
| Cormorant Asset Management, LP | 1,000,000 | $480,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 1,268,717 | $609,000 | 0.03% |
| Rhenman & Partners Asset Management AB | 201,537 | $97,000 | 0.02% |
| Spark Investment Management LLC | 120,100 | $57,000 | 0.01% |
| Squarepoint Ops LLC | 112,436 | $54,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,000,000 | $1,440,000 | 0.00% |
| CG Asset Management LLC | 23,000 | $11,000 | 0.00% |
| FRANKLIN STREET ADVISORS INC /NC | 20,000 | $10,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,000 | $13,000 | 0.00% |